New York, March 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Injection Pens Industry" - https://www.reportlinker.com/p05957125/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

• Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.
• Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.
• Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.
• Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.
• Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Injection Pens Market to Reach $47.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Injection Pens estimated at US$33.8 Billion in the year 2020, is projected to reach a revised size of US$47.2 Billion by 2027, growing at aCAGR of 4.9% over the period 2020-2027. Disposable, one of the segments analyzed in the report, is projected to record 5.9% CAGR and reach US$13 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reusable Pens segment is readjusted to a revised 4.5% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $9.2 Billion, While China is Forecast to Grow at 7.7% CAGR
- The Injection Pens market in the U.S. is estimated at US$9.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.8 Billion by the year 2027 trailing a CAGR of 7.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.

- Select Competitors (Total 43 Featured) -

• AstraZeneca PLC
• Becton, Dickinson & Company
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Haselmeier GmbH
• Merck & Co., Inc.
• Novartis International AG
• Novo Nordisk A/S
• Owen Mumford Ltd.
• Pfizer, Inc.
• Sanofi S.A.
• Ypsomed AG

Read the full report: https://www.reportlinker.com/p05957125/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Injection Pens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Injection Pens by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Injection Pens by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Disposable by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Disposable by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Disposable by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Reusable Pens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Reusable Pens by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Reusable Pens by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Diabetes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Diabetes by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Diabetes by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Arthritis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Arthritis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Arthritis by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Osteoporosis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Osteoporosis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Osteoporosis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Growth Hormone
Deficiency by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Growth Hormone Deficiency
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Growth Hormone
Deficiency by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 22: World Current & Future Analysis for Anaphylaxis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Anaphylaxis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Anaphylaxis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Injection Pens by
Type - Disposable and Reusable Pens - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 29: USA Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 30: USA 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and Reusable
Pens for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 32: USA Historic Review for Injection Pens by Application -
Diabetes, Arthritis, Osteoporosis, Growth Hormone Deficiency,
Anaphylaxis and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 33: USA 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Injection Pens
by Type - Disposable and Reusable Pens - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 35: Canada Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 36: Canada 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for Injection Pens
by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for Injection Pens by
Type - Disposable and Reusable Pens - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 41: Japan Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 42: Japan 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 43: Japan Current & Future Analysis for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 44: Japan Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

CHINA
Table 46: China Current & Future Analysis for Injection Pens by
Type - Disposable and Reusable Pens - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 47: China Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 48: China 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 49: China Current & Future Analysis for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 50: China Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 51: China 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

EUROPE
Table 52: Europe Current & Future Analysis for Injection Pens
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027 and %
CAGR

Table 53: Europe Historic Review for Injection Pens by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Injection Pens by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for Injection Pens
by Type - Disposable and Reusable Pens - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 56: Europe Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 57: Europe 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 58: Europe Current & Future Analysis for Injection Pens
by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 59: Europe Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 60: Europe 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

FRANCE
Table 61: France Current & Future Analysis for Injection Pens
by Type - Disposable and Reusable Pens - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 62: France Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 63: France 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 64: France Current & Future Analysis for Injection Pens
by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 65: France Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 66: France 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for Injection Pens
by Type - Disposable and Reusable Pens - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 68: Germany Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 69: Germany 15-Year Perspective for Injection Pens by
Type - Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 70: Germany Current & Future Analysis for Injection Pens
by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 71: Germany Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 72: Germany 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

ITALY
Table 73: Italy Current & Future Analysis for Injection Pens by
Type - Disposable and Reusable Pens - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 74: Italy Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 75: Italy 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 76: Italy Current & Future Analysis for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 77: Italy Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 78: Italy 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Injection Pens by
Type - Disposable and Reusable Pens - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 80: UK Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 81: UK 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and Reusable
Pens for the Years 2012, 2020 & 2027

Table 82: UK Current & Future Analysis for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 83: UK Historic Review for Injection Pens by Application -
Diabetes, Arthritis, Osteoporosis, Growth Hormone Deficiency,
Anaphylaxis and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 84: UK 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

SPAIN
Table 85: Spain Current & Future Analysis for Injection Pens by
Type - Disposable and Reusable Pens - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 86: Spain Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 87: Spain 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 88: Spain Current & Future Analysis for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 89: Spain Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 90: Spain 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

RUSSIA
Table 91: Russia Current & Future Analysis for Injection Pens
by Type - Disposable and Reusable Pens - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 92: Russia Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 93: Russia 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 94: Russia Current & Future Analysis for Injection Pens
by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 95: Russia Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 96: Russia 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 97: Rest of Europe Current & Future Analysis for
Injection Pens by Type - Disposable and Reusable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 98: Rest of Europe Historic Review for Injection Pens by
Type - Disposable and Reusable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 99: Rest of Europe 15-Year Perspective for Injection Pens
by Type - Percentage Breakdown of Value Sales for Disposable
and Reusable Pens for the Years 2012, 2020 & 2027

Table 100: Rest of Europe Current & Future Analysis for
Injection Pens by Application - Diabetes, Arthritis,
Osteoporosis, Growth Hormone Deficiency, Anaphylaxis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 101: Rest of Europe Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 102: Rest of Europe 15-Year Perspective for Injection
Pens by Application - Percentage Breakdown of Value Sales for
Diabetes, Arthritis, Osteoporosis, Growth Hormone Deficiency,
Anaphylaxis and Other Applications for the Years 2012, 2020 &
2027

ASIA-PACIFIC
Table 103: Asia-Pacific Current & Future Analysis for Injection
Pens by Geographic Region - Australia, India, South Korea and
Rest of Asia-Pacific Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 104: Asia-Pacific Historic Review for Injection Pens by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 105: Asia-Pacific 15-Year Perspective for Injection Pens
by Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2012, 2020 & 2027

Table 106: Asia-Pacific Current & Future Analysis for Injection
Pens by Type - Disposable and Reusable Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 107: Asia-Pacific Historic Review for Injection Pens by
Type - Disposable and Reusable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 108: Asia-Pacific 15-Year Perspective for Injection Pens
by Type - Percentage Breakdown of Value Sales for Disposable
and Reusable Pens for the Years 2012, 2020 & 2027

Table 109: Asia-Pacific Current & Future Analysis for Injection
Pens by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 110: Asia-Pacific Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 111: Asia-Pacific 15-Year Perspective for Injection Pens
by Application - Percentage Breakdown of Value Sales for
Diabetes, Arthritis, Osteoporosis, Growth Hormone Deficiency,
Anaphylaxis and Other Applications for the Years 2012, 2020 &
2027

AUSTRALIA
Table 112: Australia Current & Future Analysis for Injection
Pens by Type - Disposable and Reusable Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 113: Australia Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 114: Australia 15-Year Perspective for Injection Pens by
Type - Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 115: Australia Current & Future Analysis for Injection
Pens by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 116: Australia Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 117: Australia 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

INDIA
Table 118: India Current & Future Analysis for Injection Pens
by Type - Disposable and Reusable Pens - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 119: India Historic Review for Injection Pens by Type -
Disposable and Reusable Pens Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 120: India 15-Year Perspective for Injection Pens by Type -
Percentage Breakdown of Value Sales for Disposable and
Reusable Pens for the Years 2012, 2020 & 2027

Table 121: India Current & Future Analysis for Injection Pens
by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 122: India Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 123: India 15-Year Perspective for Injection Pens by
Application - Percentage Breakdown of Value Sales for Diabetes,
Arthritis, Osteoporosis, Growth Hormone Deficiency, Anaphylaxis
and Other Applications for the Years 2012, 2020 & 2027

SOUTH KOREA
Table 124: South Korea Current & Future Analysis for Injection
Pens by Type - Disposable and Reusable Pens - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 125: South Korea Historic Review for Injection Pens by
Type - Disposable and Reusable Pens Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 126: South Korea 15-Year Perspective for Injection Pens
by Type - Percentage Breakdown of Value Sales for Disposable
and Reusable Pens for the Years 2012, 2020 & 2027

Table 127: South Korea Current & Future Analysis for Injection
Pens by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 128: South Korea Historic Review for Injection Pens by
Application - Diabetes, Arthritis, Osteoporosis, Growth Hormone
Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 129: South Korea 15-Year Perspective for Injection Pens
by Application - Percentage Breakdown of Value Sales for
Diabetes, Arthritis, Osteoporosis, Growth Hormone Deficiency,
Anaphylaxis and Other Applications for the Years 2012, 2020 &
2027

REST OF ASIA-PACIFIC
Table 130: Rest of Asia-Pacific Current & Future Analysis for
Injection Pens by Type - Disposable and Reusable Pens -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 131: Rest of Asia-Pacific Historic Review for Injection
Pens by Type - Disposable and Reusable Pens Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 132: Rest of Asia-Pacific 15-Year Perspective for
Injection Pens by Type - Percentage Breakdown of Value Sales
for Disposable and Reusable Pens for the Years 2012, 2020 &
2027

Table 133: Rest of Asia-Pacific Current & Future Analysis for
Injection Pens by Application - Diabetes, Arthritis,
Osteoporosis, Growth Hormone Deficiency, Anaphylaxis and Other
Applications - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 134: Rest of Asia-Pacific Historic Review for Injection
Pens by Application - Diabetes, Arthritis, Osteoporosis, Growth
Hormone Deficiency, Anaphylaxis and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 135: Rest of Asia-Pacific 15-Year Perspective for

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957125/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________